Financials
Financial year 2024
Pharma pour Tous Namur from Namur, company number BE0465407186, closed financial year 2024 with a result of € 25,460 after tax. For that financial year Pharma pour Tous Namur recorded a gross margin of € 111,880 and equity of € 144,922. Compared with financial year 2023, the result moved from € 12,511 to € 25,460. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 25, 2025.
€ 144,922
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 25,460
▲ 103% vs 2023
Profit after tax over the fiscal year.
€ 89,400
▲ € 72,312 vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 25,000 paid out
98 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2024
€ 52,937
▲ 25% vs 2023
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 40,930
▲ € 39,494 vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
€ 16,749
▼ 12% vs 2023
€ 9,920 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 80,284
▲ 77% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 10,380
▼ 8% vs 2023
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 75,652 | € 81,354 | € 106,326 | € 111,880 | ▲ 5% |
| Profit after taxes | € 22,538 | € 21,292 | € 12,511 | € 25,460 | ▲ 103% |
| Equity | € 138,659 | € 146,951 | € 144,462 | € 144,922 | |
| Total debts | € 122,174 | € 113,229 | € 90,740 | € 196,014 | ▲ 116% |
| Cash | € 58,524 | € 71,303 | € 17,088 | € 89,400 | ▲ € 72,312 |
| Land & buildings | € 26,920 | € 24,564 | € 26,165 | € 20,599 | ▼ 21% |
| Retained profit | € 51,859 | € 60,151 | € 57,662 | € 58,122 | ▲ 1% |
| Dividend | € 0 | € 13,000 | € 15,000 | € 25,000 | ▲ 67% |
| Bank debt | € 38,415 | € 32,374 | € 19,010 | € 16,749 | ▼ 12% |
| Balance sheet total | € 260,833 | € 260,180 | € 235,203 | € 340,936 | ▲ 45% |
Key figures of Pharma pour Tous Namur, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to Pharma pour Tous Namur?
What happened at Pharma pour Tous Namur in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Sintia MENGA stepped down as director. NBB
- Jean-Paul KNAEPEN stepped down as director. NBB
- New annual accounts for financial year 2024: profit of € 25,460 (▲ 103% vs 2023). filed late Source: NBB ↗
- Michèle LARUTH stepped down as director. NBB
- Marc CHARLES stepped down as director. NBB
- Sintia MENGA became a director. NBB
- Jean-Paul KNAEPEN became a director. NBB
- Michèle LARUTH became a director. NBB
In short
From € 22,538 profit in 2021 to € 25,460 profit in 2024.
Paid € 29,808 in corporate taxes since 2021.
Best year ever: 2024, with € 25,460 profit.
Paid out € 53,000 in dividends to the owners in total.
A new publication or filing at Pharma pour Tous Namur? We notify you, reason included.
Follow Pharma pour Tous NamurDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Directors
According to the 2024 annual accounts
Michèle LARUTH
Director
since 2023 · until 2024
Marc CHARLES
Managing director
since 2023 · until 2024
Sintia MENGA
Director
since 2024 · until 2030
Jean-Paul KNAEPEN
Managing director
since 2024 · until 2030
Establishments
Establishment units
Physical locations of this company
Boulevard du Nord 20
5000 Namur
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0465.407.186
- VAT number
- BE 0465.407.186
- Registered office
- Boulevard du Nord 20, 5000 Namur
- Names & denominations
- Pharma pour Tous Namur
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 8 March 1999
- Peppol
- Active · Active since 10 Sept 2026
- Activities · NACE
Apothekers
Detailhandel in farmaceutische producten